TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: effective rates of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: inflammatory response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anti-fungal effect of fluconazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CR+PR rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median TTP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: G3-4 diarrhoea
Endpoint domain: Adverse events/effects
Primary endpoint: sonication time to massive gray scale change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence rates of pain in the treated region
Endpoint domain: Adverse events/effects
Primary endpoint: Mean back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of glove perforation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Surgeon satisfaction with sharp needles
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Perceived safety profile of blunt needles
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Stroop interference score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: total infections
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of referrals with relevant investigations completed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of referrals with a management plan reached within one year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean duration between first appointment and date of management plan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of HCV infection
Endpoint domain: Mortality/survival
Primary endpoint: Activated partial thromboplastin time values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Total iodine dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic acceptability score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glycated hemoglobin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with insulin treatment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Emotional Intelligence (EI) scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Loss of capture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospitalizations for worsening heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Deaths from all causes
Endpoint domain: Mortality/survival
Primary endpoint: Parent's Perceptions of Primary Care total scale scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Crestal bone level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completed encounters
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: total costs
Endpoint domain: Resource use
Primary endpoint: cosmetic satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: dengue immunoglobulin G titres
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Frequency of leprosy reactions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICD therapy episodes for life-threatening VA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Fussing behavior
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Crying behavior
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: peanut-specific IgE levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: individual recognition of major allergens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean number of stools before recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of constipation
Endpoint domain: Adverse events/effects
Primary endpoint: Classification accuracy for behavior problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum level of CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of esophageal eosinophilia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rate of reversion to normal cytologic findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return to normal life duration
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Pain and fatigue levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of neck pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Prevalence of low back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: PD (Probing Depth)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensorimotor function of the knee and leg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tracheal extubation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Side effect score
Endpoint domain: Adverse events/effects
Primary endpoint: quiescence of conjunctival cicatrization and erythema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically important bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: convulsion control rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: hospital stays
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: convulsion recurrence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: functional status scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Combined clinical endpoint (death, myocardial infarction, or target vessel revascularization)
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of neovascular glaucoma
Endpoint domain: Adverse events/effects
Primary endpoint: Severe intestinal complications requiring surgery
Endpoint domain: Adverse events/effects
Primary endpoint: restoration of full physical fitness
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: risk of life-threatening ventricular arrhythmias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Complete Response (CR) Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression-Free Survival (PFS) Rate
Endpoint domain: Mortality/survival
Primary endpoint: Oxford grade 2 or greater staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Schulze grade 30 or greater conjunctival erythema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: satisfaction with self-administration of medication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in number of consultations
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction in length of hospital stays
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Alzheimer disease risk knowledge improvement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: size of open areas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: degree of scar pliability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage depression of first twitch (T1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-regulation of asthma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: asthma-related hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VO2max
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total body BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Plasma beta-thromboglobulin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Physical symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: 1-year predictive ability for prediabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Patient satisfaction with consultation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: serious heart failure event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Preference for CEE/PC over CEE/MPA
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effect on endometrium (atrophic vs proliferative)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Height SDS for chronological age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of bone maturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Onset of puberty
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness in cardioinhibitory vasovagal syncope
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: BOP index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bacterial count at implants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: double support percentage during forward walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: double support percentage during backward walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: heel-to-heel base of support during forward walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Theta-FRN brain response to feedback
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Delta-P3 brain response to feedback
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Bodyweight measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative remission rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increase in function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: combined prevalence of overweight and obesity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Inspiratory muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Performance scores in managing deteriorating patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation between PC‐MRI and SPACE scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Good results frequency
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Atrial natriuretic factor concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Retinal sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retinal volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in potassium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in overall menopausal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in physical well-being
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvement in functional well-being
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: macrophage-derived chemokine/interferon-inducible protein-10 ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: thymus and activation-regulated chemokine/interferon-inducible protein-10 ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: LogMAR best-corrected visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV positivity
Endpoint domain: Mortality/survival
Primary endpoint: visual analogue scale (VAS) sad mood
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Degeneration rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Comprehension of participant rights
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: persistent pain and discomfort interfering with daily activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal fluorescein concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anterior chamber concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LDalp events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SDLP changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in BMI by 1 year post surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain and distress reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oswestry function scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of dominant follicles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Time to ovulation after discontinuation of OC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: pruritus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: eye irritation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention of BLS/AED skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ongoing pregnancy rates
Endpoint domain: Mortality/survival
Primary endpoint: Efficacy in mitigating and reversing photoaging signs and symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Safety of the cosmeceutical blend regimen
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in total scores of Y-BOCS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Food cravings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dependence on acid suppression for symptom relief
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Zarit Burden Interview points
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: General Self-Efficacy Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cognitive Emotion Regulation Questionnaire adaptive subscales scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rates of obtaining the health plan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity for diagnosing endometrial cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity for detecting low-risk hyperplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity for diagnosing high-risk hyperplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of problem-solving coping
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Use of avoidant coping
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Development of anti-WBC antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Development of anti-RBC antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Vagal tone during ERCP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in worst abdominal pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite pain median score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom response scale score of 2 or more
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ad libitum energy intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality of life measured by Minnesota Living With Heart Failure Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of Chronic Postoperative Pain (CPOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of Chronic Postoperative Pain (CPOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fracture resistance of teeth restored with Radix posts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Catastrophic fracture rate
Endpoint domain: Adverse events/effects
Primary endpoint: Cost-effectiveness per QALY
Endpoint domain: Resource use
Primary endpoint: Probability of falling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Balance confidence (ABC scale)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence rate of chronic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Active Range of Motion (AROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MoCA score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: mean count of fall risk reduction activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adjusted median recurrent fall rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: staff communication measures
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean monthly epistaxis duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dizziness scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance from CEJ to base of the defect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pregnancy rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: tight glucose control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants reaching the physical activity target
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete response in pleural effusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knee stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tunnel enlargement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response to therapy
Endpoint domain: Adverse events/effects
Primary endpoint: improvement in aphasia therapy outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comfort of impression making
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: SSPG concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: percentage of time maintained within INR target range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of thromboembolic events
Endpoint domain: Adverse events/effects
Primary endpoint: rate of serious bleeding events
Endpoint domain: Adverse events/effects
Primary endpoint: Neuropsychiatric symptom score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CMAI score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of non-Hodgkin lymphoma
Endpoint domain: Mortality/survival
Primary endpoint: Risk of kidney cancer
Endpoint domain: Mortality/survival
Primary endpoint: Box and block test (BBT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Static fatigue index during a maximal sustained handgrip strength test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Estimated continuous cardiac output measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: DNA tail length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes